home / stock / lgvn / lgvn news

LGVN News and Press, Longeveron Inc. From 09/09/21

Stock Information
Company Name: Longeveron Inc.
Stock Symbol: LGVN
Market: NASDAQ
Website: longeveron.com
Menu
LGVN LGVN Quote LGVN Short LGVN News LGVN Articles LGVN Message Board
Get LGVN Alerts

News, Short Squeeze, Breakout and More Instantly...
LGVN - Longeveron Announces Final Results of Phase 1 Clinical Study of Lomecel-B Injection in Hypoplastic Left Heart Syndrome Patients

--Study meets primary safety endpoint: no major adverse cardiac events (MACE), nor any treatment-related infections during the first month post-treatment. --Secondary endpoints measured per protocol suggest Lomecel-B injection may improve patient long-term clinical outcome after surgery...
LGVN - Longeveron to Present at H.C. Wainwright 23rd Annual Global Investor Conference

MIAMI, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today that management will present virtually ...

LGVN - Longeveron's (LGVN) CEO Geoff Green on Q2 2021 Results - Earnings Call Transcript

Longeveron Inc. (LGVN) Q2 2021 Earnings Conference Call August 13, 2021 8:00 AM ET Company Participants Brendan Payne – Stern Investor Relations Geoff Green – Chief Executive Officer Joshua Hare – Co-Founder, Chief Science Officer and Chairman James Clavijo – Chief...

LGVN - SESN, ACY among mid-day movers

Gainers: GreenVision Acquisition (NASDAQ:GRNV) +154%. Evoke Pharma(NASDAQ:EVOK) +29%. LifeStance Health  (NASDAQ:LFST) +24%. CVD Equipment (NASDAQ:CVV) +23%. Pilgrim's Pride Corporation (NASDAQ:PPC) +21%. AbCellera Biologics (NASDAQ:ABCL) +21%. AeroCentury (NYSE:ACY) +19%. Sesen Bio (NAS...
LGVN - How Aging-Related Conditions Are Increasing The Treatment Burden For Older Patients

Palm Beach, FL –August 13, 2021 – FinancialNewsMedia.com News Commentary – The normal aging process is characterized by a progression of physiologic events that occur throughout the life cycle. Changes associated with aging occur throughout the body and are ...

LGVN - Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty

-- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response in six-minute walk test (6MWT) at Day 180 -- Longeveron to hold conference call today at 8:00 AM EDT MIAMI, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NAS...

LGVN - Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results

MIAMI, Aug. 13, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today provided a business update and reported its financial re...
LGVN - Longeveron to Release Second Quarter 2021 Financial Results and Hold Conference Call on August 13, 2021

MIAMI, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that the Company will release its second q...

LGVN - Wall Street Breakfast: The Week Ahead (Podcast)

You can read full article here. For further details see: Wall Street Breakfast: The Week Ahead (Podcast)

LGVN - Wall Street Breakfast: The Week Ahead

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Tech heavyweights will be in the spotlight next week with Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Alphabet (NASDAQ...
Previous 10 Next 10